Updated Jul 16, 2026
Parschauer Karah Herdman has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $517K.
Karah Herdman Parschauer is the Executive Vice President and Chief Legal Officer at Ultragenyx Pharmaceutical Inc., where she plays a key role in legal affairs and compliance. She has also been involved with Tenaya Therapeutics, Inc.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-15 | RARE | Ultragenyx Pharmaceutical Inc. | S — Open-market sale | 1.9K | $24.62 | $47K |
| 2026-04-20 | RARE | Ultragenyx Pharmaceutical Inc. | A — Grant or award | 28.9K | $0.00 | |
| 2026-03-10 | RARE | Ultragenyx Pharmaceutical Inc. | S — Open-market sale | 3.5K | $22.67 | $80K |
| 2026-03-10 | RARE | Ultragenyx Pharmaceutical Inc. | S — Open-market sale | 6.0K | $21.40 | $129K |
| 2026-03-03 | RARE | Ultragenyx Pharmaceutical Inc. | S — Open-market sale | 8.1K | $22.80 | $185K |
| 2026-03-03 | RARE | Ultragenyx Pharmaceutical Inc. | A — Grant or award | 11.1K | $0.00 | |
| 2026-02-20 | EOLS | Evolus, Inc. | A — Grant or award | 45.6K | $0.00 | |
| 2025-09-12 | RARE | Ultragenyx Pharmaceutical Inc. | S — Open-market sale | 2.5K | $31.17 | $76K |
Karah Herdman Parschauer is the Executive Vice President and Chief Legal Officer at Ultragenyx Pharmaceutical Inc., where she plays a key role in legal affairs and compliance. She has also been involved with Tenaya Therapeutics, Inc.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($517K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Parschauer Karah Herdman profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.